GLP1R and type 2 diabetes mellitus: Several drug classes traditionally used to treat T2D are recognised to improve measures of steatohepatitis in MASLD guidelines [8-10], including thiazolidinediones, sodium-glucose co-transporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor analogues (GLP-1RAs).